Share
FRONTLINE Editor-in-Chief and Executive Producer Raney Aronson-Rath sits down with journalists and filmmakers for probing conversations about the investigative journalism that drives each FRONTLINE documentary and the stories that shape our time. Produced at FRONTLINE’s headquarters at GBH and powered by PRX. The FRONTLINE Dispatch is made possible by the Abrams Foundation Journalism Initiative.
…
continue reading
Manage episode 515140964 series 2882353
Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
New research has confirmed Ozempic reduces the risk of strokes and heart attacks by 20 percent - even in patients who weren't severely overweight to start with.
The study, which was led by University College London and published in The Lancet, found that weight loss accounted for only one third of this reduction.
Auckland University molecular medicine professor Peter Shepherd says this is proof other factors are behind the slowdown of heart disease.
"We know a few of them, we know a bit about how it effects heart tissue growth, we know a bit about the positive effects it has on the deposition of the lipids, but there's still a long way to go to fully understand its effects."
LISTEN ABOVE
See omnystudio.com/listener for privacy information.
10924 episodes
))
